Roger A. Jeffs, Ph.D., has led Liquidia Corporation as its CEO since January 2022. With a strong background in pharmacology, he holds a Ph.D. from the University of North Carolina and a Bachelor's in Chemistry from Duke University. Before joining...

Roger A. Jeffs, Ph.D., has led Liquidia Corporation as its CEO since January 2022. With a strong background in pharmacology, he holds a Ph.D. from the University of North Carolina and a Bachelor's in Chemistry from Duke University. Before joining Liquidia, he served for 18 years at United Therapeutics Corporation, where he was a key player in their early growth, overseeing the development of important products for rare diseases. His experience includes positions at Amgen and Burroughs Wellcome, showing a solid foundation in both research and business. In 2023, Dr. Jeffs earned a total compensation of approximately $431,000, which reflects a significant cash bonus related to the company meeting its performance goals. He is also known for his substantial stock holdings, positioning himself as a significant stakeholder in Liquidia's future. Under his leadership, Liquidia is navigating its path toward a more commercial presence in the biotechnology sector, focusing on innovative treatments.

Quick Links

1. Rivals

2. Holdings

3. Insider Trading

4. Compensation History

5. Other Liquidia Corporation CEOs

L

Roger A. Jeffs, Ph.D.

CEO of Liquidia Corporation

Education

Ph.D. in pharmacology from the University of North Carolina; Bachelor's degree in chemistry from Duke University

Field of Expertise

Healthcare & Life Sciences - Pharmacology

Sector of Economy

Healthcare

Born

January 1, 1962 - 63 years ago

CEO of Liquidia Corporation for

4 years 6 months (Jan 2021 - Present)

Previous Experience

Co-Founder and Vice Chairman of Kriya Therapeutics, former President and Chief Operating Officer of United Therapeutics Corporation

Rivals

Competitors/colleagues of Roger A. Jeffs, Ph.D.

Holdings

See how much did Roger A. Jeffs, Ph.D. make over time.

Dr. Roger Jeffs holds around 3.78 million shares of Liquidia Corporation, which represents about 4.8% of the company's stock. He has seen fluctuations in these holdings, particularly during his transition to CEO in 2022, at which point his accumulated shares...

Dr. Roger Jeffs holds around 3.78 million shares of Liquidia Corporation, which represents about 4.8% of the company's stock. He has seen fluctuations in these holdings, particularly during his transition to CEO in 2022, at which point his accumulated shares became more significant due to new stock option agreements. In recent years, his stock holdings have highlighted his confidence in the company's future after he guided Liquidia through a pivotal phase of development and performance. Notably, as of 2023, the stock holdings he not only owns outright but also controls through options could significantly impact his wealth, keeping him personally invested in Liquidia's success.

Loading...

Insider Trading

See recent insider trades of Roger A. Jeffs, Ph.D..

No insider trades found for this CEO.

Compensation History

See how much did Roger A. Jeffs, Ph.D. make over time.

In 2023, Roger A. Jeffs earned a total of about $431,080 in compensation, which included a base salary of $689,000 and a bonus reflecting his performance and that of the company over the year. This bonus of $620,100 was based on achieving corporate goals, a strong improvement from the previous year's targets. His total compensation is largely cash-based, with no stock grants reported in 2023, emphasizing his performance-driven rewards. This structure aligns his financial interests directly with Liquidia’s business performance, making sure he's focused on delivering results.

Year

2023

Total Compensation

$1.32M

Salary

$689.00K

Board Justification

The compensation program is designed to attract, retain, and reward key employees, incentivizing them to achieve performance goals aligned with the company's objectives.

Bonus

$620.10K

Board Justification

Represents cash bonus paid by the Company in January 2024 reflecting the achievement of 150% of the Company’s 2023 corporate goals, as determined by the Compensation Committee.

Other

$13.98K

Board Justification

Includes contributions to the 401(k) plan and health savings accounts.

Restricted Stock

$0.00(0 N/A)

Board Justification

No vested stock reported for 2023.

Performance Metrics

Based on the achievement of corporate goals set by the Compensation Committee.

Other Liquidia Corporation CEOs

Here are other CEOs of Liquidia Corporation

Damian deGoa

Ex-CEO of Liquidia Corporation

January 2020 - January 2022